Events MOL2NET'18, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 4th ed.

Event submissions

Published

This submission belongs to the session 06. CHEMBIOMOL-04: Chem. Biol. & Med. Chem. Workshop, Paraiba, Porto, Rostock, Germany-Galveston, Texas, USA, 2018 of the event MOL2NET'18, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 4th ed.

Published date

19 Dec, 2018

Citation

Maité Rodríguez-Díaz, Carla Delporte, Sylvia Arrau, Bruce K. Cassels, Hugo F. Miranda, Gabriela Valenzuela, Andrés Barriga, Antihyperalgesic activity of quillaic acid obtained from Quillaja saponaria Mol., in Proceedings of MOL2NET'18, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 4th ed., 15 January 2018–20 January 2019, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-04-06080

Facebook

Twitter

Antihyperalgesic activity of quillaic acid obtained from Quillaja saponaria Mol.

Maité Rodríguez-Díaz ¹

Carla Delporte ²

Sylvia Arrau ²

Bruce K. Cassels ²

Hugo F. Miranda ²

Gabriela Valenzuela ²

Andrés Barriga ²

1. Universidad Andres Bello, Chile

2. Universidad de Chile

Abstract

Background: Quillaja saponaria Mol. bark contains a high concentration of triterpene saponins that have been used for centuries as a cleansing, antiinflammatory and analgesic agent in Chilean folk medicine. In earlier studies we demonstrated, in mice, both the anti-inflammatory as well as the antinociceptive effect of the major sapogenin, quillaic acid (QA).
Objective: To determine the antihyperalgesic effect of QA one and seven days after itpl administration of complete Freund's adjuvant (CFA) in male mice using the hot plate test in the presence of complete Freund's adjuvant (HP/CFA) as an acute and chronic skeletal muscle pain model.
Methods: The present study evaluated the antihyperalgesic activity of QA against acute and chronic skeletal muscle pain models in mice using the hot plate test in the presence of complete Freund's adjuvant (HP/CFA), at 24 h (acute assay) and 7 days (chronic assay) , with dexketoprofen (DEX) as the reference drug.
Results: In acute and chronic skeletal muscle pain assays, QA at 30 mg/kg ip elicited its maximal antihyperalgesic effects (65.0% and 53.4%) at 24 h and 7 days respectively. The maximal effect of DEX (99.0 and 94.1 at 24 h and 7 days respectively) was induced at 100 mg/kg.
Conclusion: QA and DEX elicit dose-dependent antihyperalgesic effects against acute and chronic skeletal muscle pain, but QA is more potent than DEX in the early and late periods of inflammatory pain induced by CFA.

Keywords

Quillaja saponaria

quillaic acid

skeletal muscle pain

antihyperalgesic activity

complete Freund's adjuvant

Poster

MOL2NET, International Conference_Maite Rodríguez-Díaz.pdf

Creation of a Structural Database for Inhibition of Biofilm Formation

MVVM design pattern for asynchronous events in information system